Advertisement

Mesenchymal Stem Cell Isolation and Expansion Methodology

  • Mario Ricciardi
  • Luciano Pacelli
  • Giulio Bassi
  • Francesco Bifari
  • Federico Mosna
  • Mauro Krampera
Chapter
Part of the Stem Cells and Cancer Stem Cells book series (STEM, volume 3)

Abstract

Mesenchymal stem cells (MSCs) are adult non-hematopoietic stem cells originally isolated from bone marrow (BM) (Prockop, 1997), but they are virtually present and can be isolated from almost every tissue of the body (Da Silva et al., 2006), including peripheral blood (Roufosse et al., 2004). This evidence suggests that MSCs could be part of a mesenchymal-stromal cell system diffused throughout the body. The real in vivo counterpart of culture-expanded MSCs is still unknown; however, different Authors suggested that MSCs are a subgroup of vessel-lining pericytes that may contribute to vessel homeostasis by reacting to tissue damage with regenerative processes, locally modulating the inflammatory reaction, and entering systemic circulation to migrate according to cytokine gradients (Crisan et al., 2008). The International Society of Cellular Therapy (ISCT) stated the following three criteria for the definition of MSCs after in vitro expansion (Dominici et al., 2006): (1) the adherence to plastic under standard tissue culture conditions; (2) the expression of a specific combination of cell surface markers; (3) the capability of multilineage differentiation under appropriate in vitro conditions. These criteria are necessary to overcome the problems due to the absence of MSC-specific cell surface markers, the high heterogeneity in terms of differentiation potential, and the similarities to fibroblasts displayed by isolated and expanded MSCs. Consequently, ISTC suggested to define MSCs as “Multipotent Mesenchymal Stromal Cells” instead of “Mesenchymal Stem Cells”. In this Chapter, MSC isolation, expansion and functional characterization will be discussed in details.

Keywords

Mesenchymal stem cells Bone marrow Adipose tissue Amniotic fluid Senescence Differentiation 

References

  1. Abdulrazzak H, Moschidou D, Jones G, Guillot PV (2010) Biological characteristics of stem cells from fetal, cord blood and extraembryonic tissues. J R Soc 7(Suppl 6):S689–S706Google Scholar
  2. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I (2004) Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22:675–682PubMedCrossRefGoogle Scholar
  3. Bourin P, Gadelorge M, Peyrafitte J, Fleury-Cappellesso S, Gomez M, Rage C, Sensebè L (2008) Mesenchymal progenitor cells: tissue origin, isolation and culture. Transfus Med Hemother 35(3):160–167PubMedCrossRefGoogle Scholar
  4. Campagnoli C, Roberts I, Kumar S, Bennett P, Bellantuono I, Fisk N (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396–2402PubMedCrossRefGoogle Scholar
  5. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, Gini B, Bach SD, Martinello M, Bifari F, Galiè M, Turano E, Budui S, Sbarbati A, Krampera M, Bonetti B (2009) Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27(10):2624–2635PubMedCrossRefGoogle Scholar
  6. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107(1):367–372PubMedCrossRefGoogle Scholar
  7. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buehring HJ, Giacobino JP, Lazzari L, Huard J, Péault B (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301–313PubMedCrossRefGoogle Scholar
  8. Da Silva ML, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(11):2204–2213CrossRefGoogle Scholar
  9. De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100–106PubMedCrossRefGoogle Scholar
  10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8(4):315–317PubMedCrossRefGoogle Scholar
  11. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM (2007) Human first-trimester fetal MSCS express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25(3):646–654PubMedCrossRefGoogle Scholar
  12. Ho AD, Wagner W, Franke W (2008) Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10:320–330PubMedCrossRefGoogle Scholar
  13. In’t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH (2004) Isolation of mesenchymal stem cells of fetal and maternal origin from human placenta. Stem Cells 22(7):1338–1345CrossRefGoogle Scholar
  14. Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, Gorodetsky R (2006) Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37:967–976PubMedCrossRefGoogle Scholar
  15. Krampera M (2011) Mesenchymal stromal cell ‘licensing’: a multistep process. Leukemia (in press). doi:10.1038/ leu.2011.108Google Scholar
  16. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santariasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F (2006) Role for interferon-γ in the Immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24(2):386–398PubMedCrossRefGoogle Scholar
  17. Krampera M, Sartoris S, Cosmi L, Pasini A, Angeli R, Liotta F, Tinelli M, Andreini A, Mosna F, Rebellato E, Testi MG, Santarlasci V, Pizzolo G, Tridente G, Maggi E, Romagnani S, Annunziato F (2007) Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev 16:797–810PubMedCrossRefGoogle Scholar
  18. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363(9419):1439–1441PubMedCrossRefGoogle Scholar
  19. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P (2003) Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24(18):3095–3100PubMedCrossRefGoogle Scholar
  20. Lu-Lu L, Yong-Jun L, Shao-Guang Y, Qin-Jun Z, Xin W, Wei G, Zhi-Bo H, Zhen-Shu X, Yong-Xin L, Delong L, Zhi-Zhe C, Zhong-Chao H (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91(8):1017–1026Google Scholar
  21. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, Madon E, Fagioli F (2006) Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97(4):744–754PubMedCrossRefGoogle Scholar
  22. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloser A, Di Halvorsen Y, Storms RW, Goh B, Kilroy G, Wu X, Gimble JM (2006) Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24(2):376–385PubMedCrossRefGoogle Scholar
  23. Mosna F, Sensebè L, Krampera M (2010) Human bone marrow and adipose tissue mesenchymal stem cells: a user’s guide. Stem Cells Dev 19(10):1449–1470PubMedCrossRefGoogle Scholar
  24. Pochampally R (2008) Colony forming unit assays for MSCs. Methods Mol Biol 449(2):83–91PubMedCrossRefGoogle Scholar
  25. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhemopoietic tissues. Science 276:71–74PubMedCrossRefGoogle Scholar
  26. Roufosse CA, Direkze NC, Otto WR, Wright NA (2004) Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36:585–597PubMedCrossRefGoogle Scholar
  27. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131(2):324–336PubMedCrossRefGoogle Scholar
  28. Schäffler A, Büchler C (2007) Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25(4):818–827PubMedCrossRefGoogle Scholar
  29. Sensebé L, Bourin P, Tarte K (2011) Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 22(1):19–26PubMedCrossRefGoogle Scholar
  30. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24(2):462–471PubMedCrossRefGoogle Scholar
  31. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L (2007) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111(3):1327–1333PubMedCrossRefGoogle Scholar
  32. Steigman SA, Fauza DO (2007) Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr Protoc Stem Cell Biol Chapter 1: Unit 1E.2Google Scholar
  33. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, Mossafa H, Tchirkov A, Rouard H, Henry C, Splingard M, Dulong J, Monnier D, Gourmelon P, Gorin NC, Sensebé L (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115(8):1549–1553PubMedCrossRefGoogle Scholar
  34. Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, Igura K, Satoh H, Yokomi I, Nishimura T, Yamaguchi S, Yoshimura K, Rubinstein P, Takahashi TA (2011) Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 112(4):1206–1218PubMedCrossRefGoogle Scholar
  35. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang J, Mizuno H, Alfonso ZC, Frazer JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13(12):4279–4295PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Mario Ricciardi
    • 1
  • Luciano Pacelli
    • 1
  • Giulio Bassi
    • 1
  • Francesco Bifari
    • 1
  • Federico Mosna
    • 1
  • Mauro Krampera
    • 1
  1. 1.Stem Cell Research Laboratory, Section of Hematology, Department of MedicineUniversity of VeronaVeronaItaly

Personalised recommendations